Finance

Lists
Why is HNSA up 6.79%?
Dive Deeper
HNSA:STO
Hansa Biopharma AB
SEK 47.80
+6.79%
(+3.04) 1D
Nov 12, 2:04:25 PM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for HNSA...
Open
SEK 44.90
High
SEK 49.32
Low
SEK 44.66
Mkt. cap
4.86B
Avg. vol.
547.22K
Volume
1.78M
52-wk high
SEK 49.32
52-wk low
SEK 23.52
EPS
-SEK 7.90
Shares outstanding
101.76M
No. of employees
131
Open
SEK 44.90
High
SEK 49.32
Low
SEK 44.66
Mkt. cap
4.86B
Avg. vol.
547.22K
Volume
1.78M
52-wk high
SEK 49.32
52-wk low
SEK 23.52
EPS
-SEK 7.90
Shares outstanding
101.76M
No. of employees
131
News stories
From web sources and news partners
About Hansa Biopharma AB
CEOSøren Tulstrup
Employees131
Founded2007
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitehansabiopharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
30.80M
75.99M
34.57M
48.10M
Cost of goods sold
20.11M
24.66M
13.78M
22.33M
Cost of revenue
20.11M
24.66M
13.78M
22.33M
Research and development expenses
70.21M
74.43M
57.34M
67.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88.41M
101.62M
105.56M
118.93M
Operating expense
160.41M
176.02M
162.90M
186.83M
Total operating expenses
180.52M
200.67M
176.68M
209.16M
Operating income
-149.71M
-124.68M
-142.11M
-161.06M
Other non operating income
-
-
1.38M
-30.53M
EBT including unusual items
-147.56M
-169.50M
-195.87M
-259.86M
EBT excluding unusual items
-147.56M
-169.50M
-195.87M
-259.86M
Income tax expense
693.00K
396.00K
453.00K
677.00K
Effective tax rate
-0.47%
-0.23%
-0.23%
-0.26%
Other operating expenses
1.79M
-34.00K
-
28.00K
Net income
-148.26M
-169.90M
-196.32M
-260.54M
Net profit margin
-481.29%
-223.58%
-567.89%
-541.71%
Earnings per share
-1.75
-1.62
-1.93
-2.26
Interest and investment income
10.28M
-
2.55M
3.20M
Interest expense
-10.23M
-208.06M
-28.90M
-58.48M
Net interest expenses
49.00K
-208.06M
-26.35M
-55.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
-149.07M
-124.05M
-141.48M
-149.39M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps